METHOTREXATE SODIUM - Food and Drug Administration

Set ID: d9cebc09-c68d-46f5-bdcd-fd82e945cc27
Type: Indexing - product concept
Effective date: 2017-07-05
Version: 1
Source: DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
Label	Relation	Manufacturer	Effective
These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Product name	Accord Healthcare, Inc. \| Intas Pharmaceuticals Limited	2026-09-04
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	A-S Medication Solutions	2026-08-27
These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Product name	Teva Women's Health LLC	2026-06-17
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Bryant Ranch Prepack	2026-06-10
These highlights do not include all the information needed to use JYLAMVO ® safely and effectively. See full prescribing information for JYLAMVO ® . JYLAMVO ® (methotrexate) oral solution Initial U.S. Approval: 1953	Product name	SHORLA ONCOLOGY INC. \| SHORLA PHARMA LTD. \| SGS United Kingdom Limited	2026-06-08
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Bryant Ranch Prepack	2026-06-05
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Teva Pharmaceuticals USA, Inc.	2026-06-04
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Major Pharmaceuticals	2026-05-28
These highlights do not include all the information needed to use XATMEP ® safely and effectively. See full prescribing information for XATMEP. XATMEP (methotrexate) oral solution Initial U.S. Approval: 1953	Product name	Azurity Pharmaceuticals, Inc.	2026-05-28
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Accord Healthcare Inc. \| Intas Pharmaceuticals Limited	2026-05-27
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Bryant Ranch Prepack	2026-05-26
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Elite Laboratories, Inc.	2026-05-22
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Bryant Ranch Prepack	2026-05-21
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Sun Pharmaceutical Industries, Inc. \| Orion Corporation, Orion Pharma \| Orion Corporation ORION PHARMA	2026-05-21
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Bryant Ranch Prepack	2026-05-20
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Hikma Pharmaceuticals USA Inc. \| West-Ward Columbus Inc.	2026-05-20
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Alembic Pharmaceuticals Inc. \| Alembic Pharmaceuticals Limited	2026-05-18
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Elite Laboratories, Inc.	2026-05-15
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Sun Pharmaceutical Industries, Inc. \| Orion Corporation, Orion Pharma \| Orion Corporation ORION PHARMA	2026-05-14
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Zydus Pharmaceuticals USA Inc. \| Zydus Lifesciences Limited	2026-05-09
These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Product name	Teva Women's Health LLC	2026-05-08
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Aurobindo Pharma Limited \| EUGIA Pharma Specialities Limited	2026-05-07
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Mylan Pharmaceuticals Inc.	2026-05-07
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Mylan Pharmaceuticals Inc.	2026-05-07
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Teva Pharmaceuticals USA, Inc.	2026-05-07
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	NuCare Pharmaceuticals, Inc.	2026-04-30
These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Product name	Alembic Pharmaceuticals Inc. \| Alembic Pharmaceuticals Limited	2026-04-16
These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Product name	Alembic Pharmaceuticals Limited	2026-04-16
METHOTREXATE TABLETS. These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Golden State Medical Supply, Inc.	2026-04-15
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Sun Pharmaceutical Industries, Inc. \| Orion Corporation, Orion Pharma \| Orion Corporation ORION PHARMA	2026-03-25
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Hikma Pharmaceuticals USA Inc. \| West-Ward Columbus Inc.	2026-03-17
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Elite Laboratories, Inc.	2026-03-09
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Aurobindo Pharma Limited \| EUGIA Pharma Specialities Limited	2026-03-02
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Mylan Pharmaceuticals Inc.	2026-02-15
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	A-S Medication Solutions	2026-02-04
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Safecor Health LLC	2026-01-30
Methotrexate Tablets, USP Rx Only These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. Initial U.S. Approval: 1953	Product name	AvPAK	2026-01-29
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Safecor Health LLC	2026-01-21
Methotrexate Tablets, USP Rx Only These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. Initial U.S. Approval: 1953	Product name	AvKARE	2026-01-14
Methotrexate Tablets These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Chartwell RX, LLC	2025-12-17
These highlights do not include all the information needed to use XATMEP ® safely and effectively. See full prescribing information for XATMEP. XATMEP (methotrexate) oral solution Initial U.S. Approval: 1953	Product name	Azurity Pharmaceuticals, Inc.	2025-12-16
These highlights do not include all the information needed to use JYLAMVO ® safely and effectively. See full prescribing information for JYLAMVO ® . JYLAMVO ® (methotrexate) oral solution Initial U.S. Approval: 1953	Product name	SHORLA ONCOLOGY INC. \| SHORLA PHARMA LTD. \| SGS United Kingdom Limited	2025-12-15
These highlights do not include all the information needed to use RASUVO ® safely and effectively. See full prescribing information for RASUVO. RASUVO (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Product name	Medexus Pharma Inc.	2025-12-15
These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Product name	Assertio Specialty Pharmaceuticals, LLC \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.	2025-12-05
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Hikma Pharmaceuticals USA Inc. \| West-Ward Columbus Inc.	2025-12-03
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Accord Healthcare Inc. \| Intas Pharmaceuticals Limited	2025-10-29
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Teva Pharmaceuticals USA, Inc.	2025-09-22
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Major Pharmaceuticals	2025-09-15
These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Product name	Hospira, Inc. \| Hospira Australia Pty Ltd	2025-08-22
These highlights do not include all the information needed to use METHOTREXATE FOR INJECTION safely and effectively. See full prescribing information for METHOTREXATE FOR INJECTION . METHOTREXATE for Injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Product name	Fresenius Kabi USA, LLC	2025-08-19
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Mylan Institutional Inc.	2025-07-22
METHOTREXATE-methotrexate for injection, powder, lyophilized, for solution Hikma Pharmaceuticals USA Inc. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use METHOTREXATE FOR INJECTION safely and effectively. See full prescribing information for METHOTREXATE FOR INJECTION. METHOTREXATE for injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Product name	Hikma Pharmaceuticals USA Inc.	2025-07-17
These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Product name	Teva Parenteral Medicines, Inc.	2025-07-15
These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Product name	Eugia US LLC \| Mylan Laboratories Limited \| EUGIA Pharma Specialities Limited	2025-07-10
These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Product name	Hospira, Inc. \| Hospira Australia Pty Ltd	2025-06-30
These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Product name	Hospira, Inc. \| Hospira Australia Pty Ltd	2025-06-10
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Coupler LLC	2025-02-27
These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Product name	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.	2025-01-31
These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Product name	Accord Healthcare, Inc. \| Intas Pharmaceuticals Limited	2025-01-14
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	NuCare Pharmaceuticals, Inc.	2025-01-14
Methotrexate tablet, USP	Product name	Zydus Lifesciences Limited \| Zydus Pharmaceuticals USA Inc.	2024-12-05
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Bryant Ranch Prepack	2024-10-01
METHOTREXATE INJECTION, USP METHOTREXATE FOR INJECTION, USP	Product name	Hikma Pharmaceuticals USA Inc.	2024-09-05
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Proficient Rx LP	2024-08-01
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Alembic Pharmaceuticals Limited	2024-06-07
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Alembic Pharmaceuticals Inc. \| Alembic Pharmaceuticals Limited	2024-06-04
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Bryant Ranch Prepack	2024-05-17
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Bryant Ranch Prepack	2023-12-07
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Accord Healthcare Inc. \| Intas Pharmaceuticals Limited	2023-12-02
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Teva Pharmaceuticals USA, Inc.	2023-08-21
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Product name	Bryant Ranch Prepack	2023-08-15
These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Product name	Hikma Pharmaceuticals USA Inc.	2023-04-17
These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Product name	Teva Women's Health, Inc.	2021-04-30
Methotrexate Injection, USP	Product name	Fresenius Kabi USA, LLC	2021-03-24
Methotrexate Tablets USP	Product name	A-S Medication Solutions	2018-08-23

NDC, DailyMed label, Manufacturer table
NDC	DailyMed label	Manufacturer
0054-4550	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc. \| West-Ward Columbus Inc.
0054-4550-15	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc. \| West-Ward Columbus Inc.
0054-4550-25	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc. \| West-Ward Columbus Inc.
0054-8550	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc. \| West-Ward Columbus Inc.
0054-8550-25	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc. \| West-Ward Columbus Inc.
0143-9367	METHOTREXATE INJECTION, USP METHOTREXATE FOR INJECTION, USP	Hikma Pharmaceuticals USA Inc.
0143-9367-01	METHOTREXATE INJECTION, USP METHOTREXATE FOR INJECTION, USP	Hikma Pharmaceuticals USA Inc.
0143-9516	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc.
0143-9516-01	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc.
0143-9517	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc.
0143-9517-01	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc.
0143-9518	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc.
0143-9518-01	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc.
0143-9519	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc.
0143-9519-10	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc.
0143-9830	METHOTREXATE-methotrexate for injection, powder, lyophilized, for solution Hikma Pharmaceuticals USA Inc. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use METHOTREXATE FOR INJECTION safely and effectively. See full prescribing information for METHOTREXATE FOR INJECTION. METHOTREXATE for injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc.
0143-9830-01	METHOTREXATE-methotrexate for injection, powder, lyophilized, for solution Hikma Pharmaceuticals USA Inc. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use METHOTREXATE FOR INJECTION safely and effectively. See full prescribing information for METHOTREXATE FOR INJECTION. METHOTREXATE for injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Hikma Pharmaceuticals USA Inc.
0378-0014	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Bryant Ranch Prepack
0378-0014	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Mylan Institutional Inc.
0378-0014	METHOTREXATE TABLETS. These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Golden State Medical Supply, Inc.
0378-0014	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Mylan Pharmaceuticals Inc.
0378-0014	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Safecor Health LLC
0378-0014-01	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Mylan Pharmaceuticals Inc.
0555-0572	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	A-S Medication Solutions
0555-0572	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Teva Pharmaceuticals USA, Inc.
0555-0572	Methotrexate Tablets USP	A-S Medication Solutions
0555-0572	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Bryant Ranch Prepack
0555-0572-02	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Teva Pharmaceuticals USA, Inc.
0555-0572-35	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Teva Pharmaceuticals USA, Inc.
0703-3671	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Teva Parenteral Medicines, Inc.
0703-3671-01	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Teva Parenteral Medicines, Inc.
0703-3675	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Teva Parenteral Medicines, Inc.
0703-3675-01	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Teva Parenteral Medicines, Inc.
0703-3678	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Teva Parenteral Medicines, Inc.
0703-3678-01	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Teva Parenteral Medicines, Inc.
0904-7141	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Major Pharmaceuticals
0904-7141-10	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Major Pharmaceuticals
16729-277	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Accord Healthcare, Inc. \| Intas Pharmaceuticals Limited
16729-277-03	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Accord Healthcare, Inc. \| Intas Pharmaceuticals Limited
16729-277-30	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Accord Healthcare, Inc. \| Intas Pharmaceuticals Limited
16729-277-35	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Accord Healthcare, Inc. \| Intas Pharmaceuticals Limited
16729-486	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	NuCare Pharmaceuticals, Inc.
16729-486	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Bryant Ranch Prepack
16729-486	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Accord Healthcare Inc. \| Intas Pharmaceuticals Limited
16729-486	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Coupler LLC
16729-486	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Proficient Rx LP
16729-486-01	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Accord Healthcare Inc. \| Intas Pharmaceuticals Limited
16729-486-36	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Accord Healthcare Inc. \| Intas Pharmaceuticals Limited
42291-505	Methotrexate Tablets, USP Rx Only These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. Initial U.S. Approval: 1953	AvKARE
42291-505-01	Methotrexate Tablets, USP Rx Only These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. Initial U.S. Approval: 1953	AvKARE
46708-711	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Alembic Pharmaceuticals Limited
46708-711-01	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Alembic Pharmaceuticals Limited
46708-711-05	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Alembic Pharmaceuticals Limited
46708-712	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Alembic Pharmaceuticals Limited
46708-712-01	These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953	Alembic Pharmaceuticals Limited
46708-730	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Alembic Pharmaceuticals Limited
46708-730-31	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Alembic Pharmaceuticals Limited
46708-730-36	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Alembic Pharmaceuticals Limited
47335-235	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Sun Pharmaceutical Industries, Inc. \| Orion Corporation, Orion Pharma \| Orion Corporation ORION PHARMA
47335-235	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Bryant Ranch Prepack
47335-235-83	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Sun Pharmaceutical Industries, Inc. \| Orion Corporation, Orion Pharma \| Orion Corporation ORION PHARMA
47335-235-96	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Sun Pharmaceutical Industries, Inc. \| Orion Corporation, Orion Pharma \| Orion Corporation ORION PHARMA
48433-065	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Safecor Health LLC
48433-065-01	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Safecor Health LLC
48433-065-05	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Safecor Health LLC
50090-2345	Methotrexate Tablets USP	A-S Medication Solutions
50090-2345-4	Methotrexate Tablets USP	A-S Medication Solutions
50090-2345-9	Methotrexate Tablets USP	A-S Medication Solutions
50090-5457	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	A-S Medication Solutions
50090-5457-2	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	A-S Medication Solutions
50090-5457-9	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	A-S Medication Solutions
50268-554	Methotrexate Tablets, USP Rx Only These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. Initial U.S. Approval: 1953	AvPAK
50268-554-11	Methotrexate Tablets, USP Rx Only These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. Initial U.S. Approval: 1953	AvPAK
50268-554-15	Methotrexate Tablets, USP Rx Only These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. Initial U.S. Approval: 1953	AvPAK
51079-670	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Mylan Institutional Inc.
51079-670-01	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Mylan Institutional Inc.
51079-670-05	These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Mylan Institutional Inc.
51285-366	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health, Inc.
51285-366	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health LLC
51285-366-01	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health, Inc.
51285-366-01	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health LLC
51285-367	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health LLC
51285-367	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health, Inc.
51285-367-01	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health LLC
51285-367-01	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health, Inc.
51285-368	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health LLC
51285-368	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health, Inc.
51285-368-01	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health LLC
51285-368-01	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health, Inc.
51285-369	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health, Inc.
51285-369	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health LLC
51285-369-01	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health, Inc.
51285-369-01	These highlights do not include all the information needed to use TREXALL ® safely and effectively. See full prescribing information for TREXALL. TREXALL ® (methotrexate tablets), for oral use Initial U.S. Approval: 1953	Teva Women's Health LLC
51407-121	METHOTREXATE TABLETS. These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Golden State Medical Supply, Inc.
51407-121-01	METHOTREXATE TABLETS. These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953	Golden State Medical Supply, Inc.
52652-2001	These highlights do not include all the information needed to use XATMEP ® safely and effectively. See full prescribing information for XATMEP. XATMEP (methotrexate) oral solution Initial U.S. Approval: 1953	Azurity Pharmaceuticals, Inc.
52652-2001-1	These highlights do not include all the information needed to use XATMEP ® safely and effectively. See full prescribing information for XATMEP. XATMEP (methotrexate) oral solution Initial U.S. Approval: 1953	Azurity Pharmaceuticals, Inc.
52652-2001-6	These highlights do not include all the information needed to use XATMEP ® safely and effectively. See full prescribing information for XATMEP. XATMEP (methotrexate) oral solution Initial U.S. Approval: 1953	Azurity Pharmaceuticals, Inc.
54436-010	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-010-01	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-010-02	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-010-03	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-010-04	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-012	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-012-01	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-012-02	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-012-03	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-012-04	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-015	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-015-01	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-015-02	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-015-03	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-015-04	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-017	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-017-01	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-017-02	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-017-03	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-017-04	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-020	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.
54436-020-01	These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953	Antares Pharma, Inc. \| Pharmascience Inc. \| Sharp Packaging Services, LLC \| NeoPharm Labs Inc \| PPD Development, L.P.

METHOTREXATE SODIUM - Food and Drug Administration

Mapped DailyMed Labels#

Related NDC Packages#